Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20196149 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Infliximab, Regulatory T Cells, IL2 and Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Infliximab

Study has passed its completion date and status has not been verified in more than two years.